{{DISPLAYTITLE:''alpha''-Pyrrolidinobutiophenone}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 451227117
| IUPAC_name = (''RS'')-1-Phenyl-2-(1-pyrrolidinyl)-1-butanone
| image = Α-PBP.svg
| width = 200px
| drug_name = ''alpha''-Pyrrolidinobutiophenone

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = Class B
| legal_US = Schedule I
| legal_US_comment = <ref>{{cite web|title=Lists of: Scheduling Actions, Controlled Substances, Regulated Chemicals|publisher=[[United States Department of Justice|U.S. Department of Justice]], [[Drug Enforcement Administration]], Office of Diversion Control|url=http://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf|accessdate=30 August 2014}}</ref>

<!--Identifiers-->
| PubChem = 23199082
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 16251917
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C14H19NO/c1-2-13(15-10-6-7-11-15)14(16)12-8-4-3-5-9-12/h3-5,8-9,13H,2,6-7,10-11H2,1H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = GSESDIFGJCCBHN-UHFFFAOYSA-N
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 13415-54-8
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = Y4B3AXV4I4

<!--Chemical data-->
| C=14 | H=19 | N=1 | O=1 
| molecular_weight = 217.306 g/mol
| smiles = C2CCCN2C(CC)C(=O)c1ccccc1
}}

'''α-Pyrrolidinobutiophenone''' ('''α-PBP''') is a [[stimulant]] compound developed in the 1960s<ref>[http://www.google.com/patents/about?id=SPpiAAAAEBAJ&dq=3314970 Ernst Seeger. α-Pyrrolidinyl ketones. US Patent 3314970]</ref> which has been reported as a novel [[designer drug]]. It can be thought of as the [[Homology (chemistry)|homologue]] lying between the two better known drugs [[α-PPP]] and [[α-PVP]].

==Legality==

In the United States, it is a [[Schedule I controlled substance]].<ref name=federalregister>[https://www.federalregister.gov/articles/2014/03/07/2014-04997/schedules-of-controlled-substances-temporary-placement-of-10-synthetic-cathinones-into-schedule-i Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I]</ref>

Sweden's public health agency suggested to classify α-PBP as hazardous substance on November 10, 2014.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider föreslås bli klassade som hälsofarlig vara  | accessdate=29 June 2015}}</ref>

As of October 2015 α-PBP is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

==See also==
* [[α-Pyrrolidinopropiophenone]] (α-PPP)
* [[Alpha-Pyrrolidinopentiophenone|α-Pyrrolidinopentiophenone]] (α-PVP)
* [[Αlpha-Pyrrolidinopentiothiophenone|α-Pyrrolidinopentiothiophenone]] (α-PVT)
* [[Alpha-Pyrrolidinohexiophenone|α-Pyrrolidinohexiophenone]] (α-PHP)
* [[4'-Methyl-α-pyrrolidinobutiophenone]] (MPBP)
* [[3',4'-Methylenedioxy-α-pyrrolidinobutiophenone]] (MDPBP)
* [[Buphedrone]]

==References==
{{Reflist}}

{{Stimulants}}
{{Adrenergics}}
{{Dopaminergics}}

{{DEFAULTSORT:Pyrrolidinobutiophenone, alpha-}}

[[Category:Designer drugs]]
[[Category:Pyrrolidinophenones]]

{{nervous-system-drug-stub}}